Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.10.07.757473

A public-data reproducibility benchmark of a 2.5-D U-Net with a slice-level topology term for type-B aortic dissection segmentation

Abstract

Background: Type-B aortic dissection requires separation of the true and false lumina in heterogeneous, anisotropic CTA. A topology term may reduce fragmentation, but its reproducibility must be tested under a fixed case split and independent native-grid evaluation. Methods: We used the public Graz type-B aortic dissection CTA collection (40 cases; CC BY 4.0) and froze a 28/6/6 case split for training, development, and held-out testing. A compact 2.5-D U-Net trained with cross-entropy plus multiclass Dice was compared with the identical model augmented by a fixed-weight (0.5) differentiable slice-level soft clDice term. Two training seeds were run for each arm. All 40 cases passed the NRRD audit; predictions for six held-out cases were restored to their native grids and scored with case-level 3-D voxel-grid Dice, voxel-grid morphological clDice, 6-connected component counts, physical-volume error, and 2,000-resample case-level paired bootstrap intervals. Results: With seed 20261007, topology-minus-baseline differences were -0.028 (95% CI -0.053 to -0.004) for true-lumen Dice, +0.032 (-0.006 to +0.096) for true-lumen voxel-grid clDice, +0.071 (+0.037 to +0.103) for false-lumen Dice, and +0.073 (+0.048 to +0.103) for false-lumen voxel-grid clDice. With seed 20261008, the corresponding differences were -0.040 (-0.065 to -0.018), +0.013 (-0.034 to +0.071), -0.099 (-0.187 to -0.004), and -0.058 (-0.124 to -0.001). Descriptive pooled means over 12 case rows per arm were true-lumen Dice 0.577 for topology versus 0.611 for baseline and false-lumen Dice 0.409 versus 0.422; these pooled rows are not independent cases. Conclusions: Under this fixed six-case test split, the corrected slice-level topology term did not produce a consistent benefit. True-lumen Dice was lower in both seeds, while false-lumen effects reversed direction between seeds; topology-clDice changes were small and/or interval-crossing. The benchmark supports an auditable failure-analysis workflow but does not support a general topology benefit, clinical use, external generalization, or a panvascular decision system.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

You, L., Guo, Y., Zhong, X., Peng, Z., Wang, W., Shen, L., Ge, J.. 2026-10-15. A public-data reproducibility benchmark of a 2.5-D U-Net with a slice-level topology term for type-B aortic dissection segmentation. https://doi.org/10.64898/2026.10.07.757473

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Carrier-Limited Release Risk in Electrospun Nanofibers for Regenerative Endodontics: Constraint Discovery from 25 Formulations

Regenerative endodontics needs an intracanal carrier that keeps disinfecting across a dressing interval that clinicians schedule at one to four weeks, without harming the stem cells that rebuild the pulp. We ask what one completed 25-formulation electrospinning campaign of poly(vinylpyrrolidone) (PVP) fibers carrying metronidazole, ciprofloxacin, minocycline and Ca(OH)2 can decide, and use machine learning for constraint discovery and decision support rather than as a new predictor. After an audit against the source thesis, logistic regression predicts fine-fiber formation at 96% leave-one-out accuracy, but a one-threshold rule does as well, the gain over the 80% majority baseline is not significant (exact McNemar p = 0.125), and accuracy falls to 84% when mixture loading is encoded per component. Diameter models interpolate within formulation families (ridge MAE 193 nm, 95% CI 96 to 317 nm) and fail across them (R^2 < 0). Because the campaign never measured release, we assemble a same-drug, cross-carrier evidence table: 17 bounded metronidazole and ciprofloxacin observations from seven studies, with two-sided censoring. Water-soluble carriers (PVP, PVA) completed release within 80 h (PVP within 8 h); no water-insoluble monolithic carrier reached 90% within its observation window, releasing 1.5 to 50%; both within-study comparisons separate at matched loading; and blend, core-shell and thick-mat architectures released over 3 to 28 days. The PVP mats therefore carry a carrier-limited release risk, not a proven ceiling, and one dissolution experiment can confirm or overturn it. A censoring-aware screen keeps three necessarily and one possibly nondominated formulation, and fixed-budget replays show that uncertainty sampling finds failed formulations sooner, except the one it is confidently wrong about.

bioinformatics↗

CellMethMarker provides an integrated database of human cell- and tissue-type-specific DNA methylation markers

Cell- and tissue-type-specific DNA methylation markers provide epigenetic signatures of cellular identity and are widely used to infer cellular origin from bulk and single-cell methylomes. Existing resources mainly emphasize disease-associated biomarkers, methylome atlases, genomic annotations or RNA-based cell markers, leaving an unmet need for an integrated region-level resource dedicated to such markers. Here we present CellMethMarker (http://gu-zhanglab.hfcas.ac.cn/CellMethMarker), a curated database integrating 347,514 de novo markers derived from uniformly processed whole-genome and reduced-representation bisulfite sequencing datasets, 2,203,507 literature-derived marker records and harmonized metadata for 2,810 samples. CellMethMarker enables cell- and tissue-centered marker retrieval, coordinate-based search, genome-browser visualization, interactive methylation analysis and data download. In an independent single-cell methylome atlas, these markers recover the expected cell-type-associated methylation patterns, and a platform-matched reference built from them lowers the mean deconvolution error from 0.365 to 0.144. CellMethMarker therefore links region-level DNA methylation variation to cellular identity and supports methylome-based cell-type annotation and deconvolution.

bioinformatics↗

IG-28 enables identification and quantification of high-confidence isoforms from large bulk and single-cell full-length cDNA datasets

The technology to sequence full-length transcriptomes from bulk and single-cell samples has rapidly advanced. As a result, full-length cDNA datasets now reach billions of reads in size which is beyond the capability of most established isoform identification tools. Here, we introduce IG-28 which addresses this challenge with its capability to process and analyze large fl-cDNA datasets fast and using minimal computational resources. In contrast to its predecessor Mandalorion, IG-28 is not limited to bulk fl-cDNA but is capable of parsing, processing, and analyzing single-cell fl-cDNA datasets. It does so in a lightweight, flexible manner, integrating seamlessly with established scRNA-seq analysis workflows. We benchmarked IG-28 against a variety of established and new isoform identification tools using several bulk and a complex single-cell fl-cDNA dataset and found that IG-28 consistently outperformed the other tools by identifying high-confidence public isoforms.

bioinformatics↗